The German Pharmaceuticals Market is set to rise from $78.9 billion in 2019 to around $100.3 billion in 2024, representing a compound annual growth rate of 6.9%.
Major Players in the market are Pharma GmbH, Pharmaceuticals GmbH, SC AG, Abbott GmbH & Co. KG, AbbVie Germany GmbH & Co. KG, AbZ-Pharma GmbH, EGIS Pharmaceuticals Plc, Gedeon Richter Ltd, GlaxoSmithKline Plc., Les Laboratoires Servier, Novartis AG,
AbbVie Oct 2020, a research-based global biopharmaceutical company, today announced the presentation of new data on RINVOQ (upadacitinib) and HUMIRA® (adalimumab) across multiple rheumatic diseases at the American College of Rheumatology's annual meeting (ACR Convergence 2020), to be held virtually November 5-9. A total of 38 abstracts, including seven oral presentations, will be presented from a broad range of studies in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.
Increasing research initiatives to develop novel drugs for treatment against different viruses is expected to boost the Germany pharmaceuticals market. For instance, in March 2020, a study was published by a group of scientists from Germany that demonstrated the use of Camostat Mesylate against COVID-19 caused by SARS–CoV-2 coronavirus. The study found that SARS-CoV-2 requires a cellular protein TMPRSS2 in the human body to enter host cells. Therefore, the Japanese FDA approved the drug Camostat Mesylate which is active against coronavirus and has the potential to block TMPRSS2.
Nov 2020- Positive data on BioNTech and U.S. partner Pfizer NSE -0.87 % Inc's Covid-19 vaccine is an unlikely success for the married couple behind the German biotech firm, who have devoted their lives to harnessing the immune system against cancer. Pfizer said on Monday said its experimental vaccine was more than 90% effective in preventing Covid-19 based on initial data from a large study. Pfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial.
ICPPN Germany 2021 welcomes all participants throughout the world to attend the International Conference on Pharmacy and Pharma Network held on June 28-30, 2021 in Germany. The Conference deals with the theme on "Recent Innovations and Advances in Pharmacy and Pharma Networks" and it has a branch of Scientific Sessions concerned with the departments of Pharmacology, Pharmacognosy, Toxicology, Pharmaceutical Sciences, Clinical Pharmacy, Biopharmaceutics and which included with subdivisions they are Hospital Pharmacy, Industrial Pharmacy, Pharmaceutical Biotechnology, Medicinal Chemistry, Pharmaceutical Nanotechnology, Pharmaceutical Microbiology.
Germany pharmaceutical market segmentation by type consists of General and Branded. By Synthesis it will be Biotech and Synthetic. By Application it contains Oncology, Blood disorder, metabolic disease and Infectious disease.
For more information contact @